STOCK TITAN

Nano-X Imaging Ltd. Form 4 Filings

NNOX NASDAQ

Every Form 4 that Nano-X Imaging Ltd. (NNOX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow NNOX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NNOX filings page.

Rhea-AI Summary

Nano-X Imaging Ltd. director and Chief Executive Officer Erez Meltzer reported purchasing 9,443 Ordinary Shares on August 10, 2026 at $1.03 per share. The shares were bought indirectly through Oud Nof, a company wholly owned by him, bringing that entity’s holdings to 45,443 Ordinary Shares. He also reports direct ownership of 60,584 Ordinary Shares, and three existing stock option grants over 40,234, 300,000, and 150,000 underlying Ordinary Shares at exercise prices of $2.21, $23.84, and $11.52, expiring in 2030, 2032, and 2034, respectively. The later option grant from April 16, 2024 vests over four years and is scheduled to be fully vested by April 16, 2028.

Rhea-AI Summary

Nano-X Imaging Ltd. director Suesskind Dan S reported open-market purchases of a total of 50,000 Ordinary Shares on July 27, 2026, in two blocks of 25,000 shares at $0.94 and $0.92 per share. The Rule 10b5-1 checkbox was not marked for these transactions.

He also reports outstanding stock options to acquire 12,505 shares at $64.6100, 50,000 shares at $17.6300, and 10,000 shares at $11.5200, with expirations between 2031 and 2033, plus time-vested RSUs granted in 2024 and 2025.

Rhea-AI Summary

Nano-X Imaging Ltd. director Kainan Noga purchased 33,000 ordinary shares on July 28, 2026 at $0.9000 per share in an open-market or private transaction. He also reports existing stock options over 12,505, 50,000 and 10,000 shares at exercise prices of $64.6100, $17.6300 and $11.5200, plus 794 ordinary shares held indirectly through I.B.L. Business Consulting Ltd. Additional ordinary shares are reported as underlying restricted share units granted December 10, 2025 that vest in twelve equal monthly installments.

Rhea-AI Summary

Nano-X Imaging Ltd. CFO Daniel Ran reported a disposition of 1,000 Ordinary Shares back to the issuer on 2026-07-29 at $0.89 per share. After this issuer-related transaction, Ran directly holds 5,950 Ordinary Shares. The transaction is classified as a disposition to the issuer and was not marked as made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Nano-X Imaging Chief Executive Officer Erez Meltzer, through his wholly owned company Oud Nof, purchased 36,000 ordinary shares on July 27, 2026 at $0.93 per share, reported as indirect ownership. The report also lists existing direct holdings of 60,584 shares and several vested and vesting stock option grants with exercise prices between $2.21 and $23.84, expiring from 2030 to 2034.

Rhea-AI Summary

Nano-X Imaging Ltd. director Alroy Erez sold 678 ordinary shares on June 10, 2026 at $1.65 per share in open-market transactions. A footnote explains that the reported sale of ordinary shares was used to cover tax liabilities arising from the vesting of restricted share units.

Following these transactions, Erez continues to hold ordinary shares tied to RSU grants, including 6,753 and 17,075 ordinary shares remaining or issuable under two separate awards. He also holds stock options over 10,000 ordinary shares at an exercise price of $11.52 expiring on December 31, 2033, and options over 50,000 ordinary shares at an exercise price of $17.63 expiring on December 28, 2032.

Rhea-AI Summary

Nano-X Imaging Ltd. CFO Daniel Ran reported a disposition of ordinary shares back to the company. On March 18, 2026, he transferred 39,474 ordinary shares to the issuer at a stated price of $0.00 per share. After this issuer-related disposition, he directly holds 46,424 ordinary shares, according to the filing.